Intelligence Platform
Patents
Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8715645
Viral vectors encoding apoptosis-inducing proteins and methods for making and using the sa
granted patentUS 8716246
Azuvirin peptides
granted patentUS 8715689
Chimeric west nile/dengue viruses
granted patentUS 8709443
Reovirus for the treatment of cellular proliferative disorders
granted patentUS 8703938
Hepatitis C virus inhibitors
granted patentUS 8703735
Antisense antiviral compounds and methods for treating a filovirus infection
granted patentUS 8697704
Hepatitis C virus inhibitors
granted patentUS 8697858
Antisense antiviral compound and method for treating influenza viral infection
granted patentUS 8691241
Reoviruses having modified sequences
granted patentUS 8685411
Rotavirus antigens
granted patentUS 8685722
Bovine adeno-associated viral (BAAV) vector and uses thereof
granted patentUS 8685734
Viral purification methods
granted patentUS 8680046
Inhibitors of viral integrase and methods of use
granted patentUS 8680065
Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and m
granted patentUS 8674118
Compounds and methods for the treatment or prevention of flavivirus infections
granted patentUS 8673316
Avirulent, immunogenic flavivirus chimeras
granted patentUS 8673629
Recombinant Rift Valley fever (RVF) viruses and methods of use
granted patentUS 8664273
Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to trea
granted patentUS 8663950
Production of a monoclonal antibody therapeutic against west nile virus in plants
granted patentUS 8663968
Simian T-cell lymphotropic virus
granted patentUS 8663624
Adeno-associated virus virions with variant capsid and methods of use thereof
granted patentUS 8663622
Recombinant vaccine viruses expressing IL-15 and methods using the same
granted patentUS 8658674
Thiophene analogues for the treatment or prevention of flavivirus infections
granted patentUS 8658616
Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of h
granted